Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001167 · ClinicalTrials.gov registry record
Ultrasound Evaluation of Tongue Movements in Speech and Swallowing
A clinical trial of Polymyositis and Speech Disorder, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 570
- Enrollment target
- 1
- Study location
NCT00001167: Completed study of Polymyositis and Speech Disorder, sponsored by National Institutes of Health Clinical Center (CC).
NCT00001167 is a study of Polymyositis and Speech Disorder that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 570 participants, below the 1,002-participant average among 8 other Polymyositis trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001167, a study of Polymyositis and Speech Disorder, has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 570 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the use of ultrasound-a test that uses sound waves to produce images-as a diagnostic tool for evaluating speech and swallowing. The following categories of individuals may be eligible for this study: 1) healthy volunteers between 20 and 85 years old with normal speech and hearing, 2) patients 6 to 85 years old with developmental neurological deficits in speech or swallowing, and 3) patients with tumors of the oral cavity, pharynx or larynx being treated at the Greater Baltimore Medical Center. Participants will undergo a 30-minute speech and oral motion evaluation, in which they imitate sounds, words and oral movements while a speech pathologist evaluates their lip, tongue and palate movements. They may also be asked to drink a small amount of water for examination of swallowing function. For the ultrasound examination, a 3/4-inch transducer (device for transmitting and receiving sound waves) is placed under the participant's chin. While the transducer is in place, the subject 1) repeats sounds and a series of syllables in several sequences, 2) swallows three times with and without a small amount of water, and 3) swallows 3 teaspoons of non-fat pudding. The ultrasound images are recorded on tape for later analysis.
Conditions Studied
Study Locations (1)
Maryland
- Warren G. Magnuson Clinical Center (CC) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 570 participants |
| Start Date | 1979-08 |
| Est. Completion | 2004-11 |
What the finished NCT00001167 record still lists
NCT00001167 is an observational study that tracks outcomes without assigning an intervention. The registered 570 participants enrollment target is mid-sized for trials with a published cap, below the 1,002-participant average among 8 other Polymyositis trials with a reported enrollment target (43% lower).
The record links to 5 conditions, with Polymyositis appearing as the primary indexed condition, and to 0 interventions.
NCT00001167 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001167 about?
NCT00001167 is a clinical study titled "Ultrasound Evaluation of Tongue Movements in Speech and Swallowing". This study will assess the use of ultrasound-a test that uses sound waves to produce images-as a diagnostic tool for evaluating speech and swallowing. The following categories of individuals may be eligible for this study: 1) healthy volunteers between 20 and 85 years old with normal speech and hea...
What is the current status of trial NCT00001167?
This trial is currently completed. The enrollment target is 570 participants. The study started on 1979-08. Estimated completion is 2004-11.
What conditions does trial NCT00001167 study?
This clinical trial studies the following conditions: Polymyositis, Speech Disorder, Pharyngeal Neoplasm, Otorhinolaryngologic Disease, Otorhinolaryngologic Neoplasm.
Who is sponsoring clinical trial NCT00001167?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001167 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polymyositis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00001167's enrollment target sits among peer trials
570 5th of 8 higher than 4 of 8 other Polymyositis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Polymyositis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
RECRUITING · Phase 3
-
Adult and Juvenile Myositis
RECRUITING
-
Rheumatology Patient Registry and Biorepository
RECRUITING
-
MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
RECRUITING
-
Environmental Risk Factors for the Anti-synthetase Syndrome
RECRUITING
-
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000645 · 570 participants · NA
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
- NCT06239844 · 570 participants · NA
Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English
- NCT06701903 · 570 participants · Phase 2
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
- NCT07266831 · 570 participants · Phase 2
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia